130 related articles for article (PubMed ID: 34373985)
1. Colorectal Cancer Cell Differentiation Is Dependent on the Repression of Aerobic Glycolysis by NDRG2-TXNIP Axis.
Hu J; Feng L; Ren M; Zhao Y; Lu G; Lu X; Li Y; Wang X; Bu X; Wang S; Shen L; He S
Dig Dis Sci; 2022 Aug; 67(8):3763-3772. PubMed ID: 34373985
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
[TBL] [Abstract][Full Text] [Related]
3. NDRG2 facilitates colorectal cancer differentiation through the regulation of Skp2-p21/p27 axis.
Shen L; Qu X; Li H; Xu C; Wei M; Wang Q; Ru Y; Liu B; Xu Y; Li K; Hu J; Wang L; Ma Y; Li M; Lai X; Gao L; Wu K; Yao L; Zheng J; Zhang J
Oncogene; 2018 Mar; 37(13):1759-1774. PubMed ID: 29343851
[TBL] [Abstract][Full Text] [Related]
4. Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP.
Shen L; O'Shea JM; Kaadige MR; Cunha S; Wilde BR; Cohen AL; Welm AL; Ayer DE
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5425-30. PubMed ID: 25870263
[TBL] [Abstract][Full Text] [Related]
5. Suppression of N-myc downstream-regulated gene 2 is associated with induction of Myc in colorectal cancer and correlates closely with differentiation.
Shi H; Jin H; Chu D; Wang W; Zhang J; Chen C; Xu C; Fan D; Yao L
Biol Pharm Bull; 2009 Jun; 32(6):968-75. PubMed ID: 19483300
[TBL] [Abstract][Full Text] [Related]
6. KLF4 inhibits colorectal cancer cell proliferation dependent on NDRG2 signaling.
Ma Y; Wu L; Liu X; Xu Y; Shi W; Liang Y; Yao L; Zheng J; Zhang J
Oncol Rep; 2017 Aug; 38(2):975-984. PubMed ID: 28656310
[TBL] [Abstract][Full Text] [Related]
7. c-Myc-driven glycolysis via TXNIP suppression is dependent on glutaminase-MondoA axis in prostate cancer.
Qu X; Sun J; Zhang Y; Li J; Hu J; Li K; Gao L; Shen L
Biochem Biophys Res Commun; 2018 Oct; 504(2):415-421. PubMed ID: 30103944
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of NDRG2 gene expression in human colorectal cancer involves promoter methylation and microRNA-650.
Feng L; Xie Y; Zhang H; Wu Y
Biochem Biophys Res Commun; 2011 Mar; 406(4):534-8. PubMed ID: 21352815
[TBL] [Abstract][Full Text] [Related]
9. NDRG2 ablation reprograms metastatic cancer cells towards glutamine dependence
Ding M; Bu X; Li Z; Xu H; Feng L; Hu J; Wei X; Gao J; Tao Y; Cai B; Liu Y; Qu X; Shen L
Int J Biol Sci; 2020; 16(16):3100-3115. PubMed ID: 33162818
[No Abstract] [Full Text] [Related]
10. Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion.
Hong SN; Kim SJ; Kim ER; Chang DK; Kim YH
J Gastroenterol Hepatol; 2016 Jan; 31(1):164-71. PubMed ID: 26250123
[TBL] [Abstract][Full Text] [Related]
11. Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications.
Iqbal MA; Chattopadhyay S; Siddiqui FA; Ur Rehman A; Siddiqui S; Prakasam G; Khan A; Sultana S; Bamezai RN
FEBS J; 2021 Jan; 288(2):471-485. PubMed ID: 32356386
[TBL] [Abstract][Full Text] [Related]
12. NDRG2 inhibition of glycolysis in liver tumor cells is regulated by SIRT1.
Zhang L; Kang J; Xin B; Cao W
J Gastrointest Oncol; 2023 Apr; 14(2):563-571. PubMed ID: 37201050
[TBL] [Abstract][Full Text] [Related]
13. Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis.
Li Q; Li Y; Liang L; Li J; Luo D; Liu Q; Cai S; Li X
Cell Commun Signal; 2018 Jun; 16(1):26. PubMed ID: 29884183
[TBL] [Abstract][Full Text] [Related]
14. [Expression and significance of new candidate tumor suppressor gene N-Myc downstream-regulated gene 2 in colorectal cancer].
Shi H; Wang WZ; Yao LB; Zhang J; Yin Q; Xu CS; Chu DK; Dong GL; Zhang HW; Li JP
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):281-4. PubMed ID: 19434539
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-responsive miR-346 promotes proliferation, migration, and invasion of renal cell carcinoma cells via targeting NDRG2.
Su ZH; Liao HH; Lu KE; Chi Z; Qiu ZQ; Jiang JM; Wu Z
Neoplasma; 2020 Sep; 67(5):1002-1011. PubMed ID: 32453597
[TBL] [Abstract][Full Text] [Related]
16. TXNIP Links Anticipatory Unfolded Protein Response to Estrogen Reprogramming Glucose Metabolism in Breast Cancer Cells.
Wang Y; Chen S
Endocrinology; 2022 Jan; 163(1):. PubMed ID: 34614512
[TBL] [Abstract][Full Text] [Related]
17. NDRG2 expression decreases with tumor stages and regulates TCF/beta-catenin signaling in human colon carcinoma.
Kim YJ; Yoon SY; Kim JT; Song EY; Lee HG; Son HJ; Kim SY; Cho D; Choi I; Kim JH; Kim JW
Carcinogenesis; 2009 Apr; 30(4):598-605. PubMed ID: 19237607
[TBL] [Abstract][Full Text] [Related]
18. MiR-181a-5p facilitates proliferation, invasion, and glycolysis of breast cancer through NDRG2-mediated activation of PTEN/AKT pathway.
Zhai Z; Mu T; Zhao L; Li Y; Zhu D; Pan Y
Bioengineered; 2022 Jan; 13(1):83-95. PubMed ID: 34951340
[TBL] [Abstract][Full Text] [Related]
19. N-myc downstream-regulated gene 2 expression is associated with glucose transport and correlated with prognosis in breast carcinoma.
Ma J; Liu W; Guo H; Li S; Cao W; Du X; Lei S; Hou W; Xiong L; Yao L; Li N; Li Y
Breast Cancer Res; 2014 Mar; 16(2):R27. PubMed ID: 24636131
[TBL] [Abstract][Full Text] [Related]
20. 3-Bromopyruvic acid regulates glucose metabolism by targeting the c-Myc/TXNIP axis and induces mitochondria-mediated apoptosis in TNBC cells.
Li J; Pan J; Liu Y; Luo X; Yang C; Xiao W; Li Q; Yang L; Zhang X
Exp Ther Med; 2022 Aug; 24(2):520. PubMed ID: 35837063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
